Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V H Donaldson

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Laboratory and Clinical Medicine|December 1, 1972
The inhibitory properties of plasma against activated plasma thromboplastin antecedent (factor XIa) in hereditary angioneurotic edemaO D Ratnoff, J Pensky, V H Donaldson, et al.
The Journal of Clinical Investigation|September 1, 1977
Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasmaV H Donaldson, J Kleniewski, H Saito, et al.
Proceedings of the Association of American Physicians|May 23, 1998
An HMG-I protein from human endothelial cells apparently is secreted and impairs activation of Hageman factor (factor XII)V H Donaldson, C J Wagner, B H Mitchell, et al.
Blood|February 15, 1990
Interactions of C1(-)-inhibitors from normal persons and patients with type II hereditary angioneurotic edema with purified activated Hageman factor (factor XIIa)V H Donaldson, B H Mitchell, B Everson, et al.
Behring Institute Mitteilungen|December 1, 1993
C1-inhibitor: structure/function and biologic roleK S Aulak, V H Donaldson, M Coutinho, et al.
Blood|June 1, 1986
Purification of Hageman factor (factor XII) on columns of popcorn-agaroseO D Ratnoff, B Everson, V H Donaldson, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1978
Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complementJ S Pitts, V H Donaldson, J Forristal, et al.
Current Topics in Hematology|January 1, 1980
Genetics of complementD Raum, V H Donaldson, F S Rosen, et al.
Protein Science : a Publication of the Protein Society|May 1, 1993
Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centersK S Aulak, A E Davis, V H Donaldson, et al.
The New England Journal of Medicine|December 1, 1977
Fatal vascular disease in a patient with Hageman trait and a connective-tissue disorderV H Donaldson, A J McAdams, E J Stratman, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Laboratory and Clinical Medicine|December 1, 1972
The inhibitory properties of plasma against activated plasma thromboplastin antecedent (factor XIa) in hereditary angioneurotic edemaO D Ratnoff, J Pensky, V H Donaldson, et al.
The Journal of Clinical Investigation|September 1, 1977
Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasmaV H Donaldson, J Kleniewski, H Saito, et al.
Proceedings of the Association of American Physicians|May 23, 1998
An HMG-I protein from human endothelial cells apparently is secreted and impairs activation of Hageman factor (factor XII)V H Donaldson, C J Wagner, B H Mitchell, et al.
Blood|February 15, 1990
Interactions of C1(-)-inhibitors from normal persons and patients with type II hereditary angioneurotic edema with purified activated Hageman factor (factor XIIa)V H Donaldson, B H Mitchell, B Everson, et al.
Behring Institute Mitteilungen|December 1, 1993
C1-inhibitor: structure/function and biologic roleK S Aulak, V H Donaldson, M Coutinho, et al.
Blood|June 1, 1986
Purification of Hageman factor (factor XII) on columns of popcorn-agaroseO D Ratnoff, B Everson, V H Donaldson, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1978
Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complementJ S Pitts, V H Donaldson, J Forristal, et al.
Current Topics in Hematology|January 1, 1980
Genetics of complementD Raum, V H Donaldson, F S Rosen, et al.
Protein Science : a Publication of the Protein Society|May 1, 1993
Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centersK S Aulak, A E Davis, V H Donaldson, et al.
The New England Journal of Medicine|December 1, 1977
Fatal vascular disease in a patient with Hageman trait and a connective-tissue disorderV H Donaldson, A J McAdams, E J Stratman, et al.
Pageof 7